Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine
ClinicalTrials.gov study NCT00365144. IPD Sharing: Not stated. Countries: 1. Publications: 1.
S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
ClinicalTrials.gov study NCT00445601. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma
ClinicalTrials.gov study NCT04088188. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT01589094. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma
ClinicalTrials.gov study NCT01532687. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC
ClinicalTrials.gov study NCT03717155. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov study NCT02101775. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)
ClinicalTrials.gov study NCT01964430. IPD Sharing: Not stated. Countries: 21. Publications: 6.
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
ClinicalTrials.gov study NCT00637247. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small
ClinicalTrials.gov study NCT04216316. IPD Sharing: YES. Countries: 1. Publications: 1.
Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)
ClinicalTrials.gov study NCT03377491. IPD Sharing: Not stated. Countries: 20. Publications: 9.
A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or
ClinicalTrials.gov study NCT05171647. IPD Sharing: YES. Countries: 13. Publications: 1.
Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine
ClinicalTrials.gov study NCT00753714. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
ClinicalTrials.gov study NCT00810719. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase II Study of Gemcitabine+Romidepsin in the Relapsed/Refractory Peripheral T-cell Lymphoma Patients
ClinicalTrials.gov study NCT01822886. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of GSK1120212 Plus Gemcitabine vs Placebo Plus Gemcitabine in Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT01231581. IPD Sharing: Not stated. Countries: 2. Publications: 1.
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed b
ClinicalTrials.gov study NCT02562716. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT02178436. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01121393. IPD Sharing: Not stated. Countries: 3. Publications: 7.
Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma
ClinicalTrials.gov study NCT02631590. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.